跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Gorizine
Approved
STANDARD
Gorizine
XL Laboratories Pvt., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8303bc59b61a6268
Company
XL Laboratories Pvt., Ltd.
Type
Standard
Approval Details
Approval Id
8303bc59b61a6268
Drug Approval Philippines Name
Gorizine
Product Name
Gorizine
Registration Number
DRP-3100-03
Brand Name
Gorizine
Generic Name
Cinnarizine
Dosage Form
Tablet
Dosage Strength
25mg
Manufacturer
XL Laboratories Pvt., Ltd.
Importer
AMBICA INTERNATIONAL TRADING CORP.
Distributor
Applied Pharmaceutical Distribution
Issuance Date
25 March 2024
Expiry Date
05 July 2029
Pharmacologic Category
Anti-Vertigo
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8303bc59b61a6268
Type
Standard
Back to Philippines FDA Approvals
Gorizine - Philippines FDA Drug Approval Details